Tech Company Financing Transactions

BioPhy Funding Round

BioPhy secured a $4.5 million financing round on 11/7/2023. Investors included Audere Capital, private investors and Metodora Ventures.

Transaction Overview

Company Name
Announced On
11/7/2023
Transaction Type
Venture Equity
Amount
$4,500,000
Round
Undisclosed
Investors

Audere Capital (Lead Investor)

private investors (Lead Investor) (Chelsea Clinton)

private investors (Lead Investor) (Jeff Marrazzo)

Metodora Ventures (Lead Investor)

TRCM Fund (Lead Investor)

Proceeds Purpose
The company intends to use the funds to expand its R&D sector, operations and its business reach.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
1650 Market St 4810
Philadelphia, PA 19103
USA
Email Address
Overview
BioPhy's patent pending AI brings predictability and quantifiable risk to drug development.
Profile
BioPhy LinkedIn Company Profile
Social Media
BioPhy Company Twitter Account
Company News
BioPhy News
Facebook
BioPhy on Facebook
YouTube
BioPhy on YouTube

Management Team

Title
Name
Email & Social
Chief Financial Officer
Steven Truong
  Steven Truong LinkedIn Profile  Steven Truong Twitter Account  Steven Truong News  Steven Truong on Facebook


 

 

Browse more venture capital transactions:

Prev: 11/7/2023: Summer venture capital transaction
Next: 11/7/2023: Lucent Bio venture capital transaction

 

Share this article

 


Where The Data Comes From

We do our best to report on all VC transactions involving tech companies. VC investment data records on this site are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary